Application of Biomarkers in the Development of Drugs Intended for the Treatment of Osteoarthritis: OARSI FDA Osteoarthritis Biomarkers Working Group

OBJECTIVE: Osteoarthritis (OA) is a chronic and slowly progressive disease for which biomarkers may be able to provide a more rapid indication of therapeutic responses to therapy than is currently available; this could accelerate and facilitate OA drug discovery and development programs. The goal of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kraus, Virginia Byers, Burnett, Bruce, Coindreau, Javier, Cottrell, Susan, Eyre, David, Gendreau, Michael, Gardiner, Jennifer, Garnero, Patrick, Hardin, John, Henrotin, Yves, Heinegård, Dick, Ko, Amy, Lohmander, Stefan, Matthews, Gloria, Menetski, Joseph, Moskowitz, Roland, Persiani, Stefano, Poole, Robin, Rousseau, Jean Charles, Todman, Martin
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3568396/
https://ncbi.nlm.nih.gov/pubmed/21396468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.joca.2010.08.019
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki